QIAGEN Reports Results for Fourth Quarter and Full-Year 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Qiagen (QGEN) Tops Q4 EPS by 4c, Revenues Beat; Offers FY20 EPS Guidance Above Consensus
February 4, 2020 4:15 PM ESTQiagen (NYSE: QGEN) reported Q4 EPS of $0.48, $0.04 better than the analyst estimate of $0.44. Revenue for the quarter came in at $413.5 million versus the consensus estimate of $408.58 million.
Delivers on Q4 2019 net sales outlook, exceeds on adjusted EPSNet sales of $413.5 million (+3% actual, +4% CER, vs. ~+3% CER outlook)Diluted EPS $0.19; adjusted EPS $0.48 ($0.48 CER, +20% CER vs. ~$0.45-0.46 CER outlook)Adjusted operating income margin rises to 33.5% of sales vs. 29.6% in Q4 2018Achieves FY 2019 net sales outlook, exceeds on adjusted EPSNet sales of $1.53 billion (+2% actual, +4% CER, vs. ~+4% CER outlook)Net loss per... More